Advertisement
Screener

NRC Health (NRC) Operating Income

NRC Health Operating Income

NRC Health (NRC) reported Operating Income of -$3.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-04

  • NRC Health operating income (loss) for the quarter ending 2026-06-30 was -$3.24M, a 303.90% decline year-over-year.
  • NRC Health operating income (loss) for the quarter ending 2026-03-31 was $5.57M, a 35.21% decline year-over-year.
  • NRC Health operating income (loss) for the quarter ending 2025-12-31 was $4.67M, a 51.30% decline year-over-year.
  • NRC Health operating income (loss) for the quarter ending 2025-09-30 was $7.74M, a 3.03% decline year-over-year.
  • NRC Health operating income (loss) for fiscal 2025 was $22.59M, a 35.81% decline from fiscal 2024.
  • NRC Health operating income (loss) for fiscal 2024 was $35.19M, a 12.11% decline from fiscal 2023.
  • NRC Health operating income (loss) for fiscal 2023 was $40.05M, a 13.96% decline from fiscal 2022.
  • NRC Health operating income (loss) for fiscal 2022 was $46.54M, a 7.41% decline from fiscal 2021.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$3.24M
10-Q · filed 2026-08-04
$2.33M
10-Q · filed 2026-08-04
$7.00M
derived: sum of 3 quarters · filed 2026-08-04
$14.74M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$5.57M
10-Q · filed 2026-05-06
$10.24M
derived: sum of 2 quarters · filed 2026-05-06
$17.98M
derived: sum of 3 quarters · filed 2026-05-06
$19.56M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$4.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$12.41M
derived: sum of 2 quarters · filed 2026-03-05
$13.99M
derived: sum of 3 quarters · filed 2026-08-04
$22.59M
10-K · filed 2026-03-05
2025-09-30$7.74M
10-Q · filed 2025-11-07
$9.33M
derived: sum of 2 quarters · filed 2026-08-04
$17.92M
10-Q · filed 2025-11-07
$27.51M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$1.59M
10-Q · filed 2026-08-04
$10.18M
10-Q · filed 2026-08-04
$19.77M
derived: sum of 3 quarters · filed 2026-08-04
$27.75M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$8.60M
10-Q · filed 2026-05-06
$18.18M
derived: sum of 2 quarters · filed 2026-05-06
$26.16M
derived: sum of 3 quarters · filed 2026-05-06
$35.03M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$9.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$17.57M
derived: sum of 2 quarters · filed 2026-03-05
$26.43M
derived: sum of 3 quarters · filed 2026-03-05
$35.19M
10-K · filed 2026-03-05
2024-09-30$7.98M
10-Q · filed 2025-11-07
$16.84M
derived: sum of 2 quarters · filed 2025-11-07
$25.61M
10-Q · filed 2025-11-07
$37.31M
derived: sum of 4 quarters · filed 2026-03-05
2024-06-30$8.87M
10-Q · filed 2025-08-08
$17.63M
10-Q · filed 2025-08-08
$29.33M
derived: sum of 3 quarters · filed 2026-03-05
$39.29M
derived: sum of 4 quarters · filed 2026-03-05
2024-03-31$8.76M
10-Q · filed 2025-05-09
$20.47M
derived: sum of 2 quarters · filed 2026-03-05
$30.42M
derived: sum of 3 quarters · filed 2026-03-05
$39.79M
derived: sum of 4 quarters · filed 2026-03-05
2023-12-31$11.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$21.66M
derived: sum of 2 quarters · filed 2026-03-05
$31.03M
derived: sum of 3 quarters · filed 2026-03-05
$40.05M
10-K · filed 2026-03-05
2023-09-30$9.96M
10-Q · filed 2024-11-08
$19.32M
derived: sum of 2 quarters · filed 2024-11-08
$28.34M
10-Q · filed 2024-11-08
$40.58M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$9.37M
10-Q · filed 2024-08-08
$18.38M
10-Q · filed 2024-08-08
$30.62M
derived: sum of 3 quarters · filed 2025-03-17
$41.73M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31$9.02M
10-Q · filed 2024-05-09
$21.26M
derived: sum of 2 quarters · filed 2025-03-17
$32.37M
derived: sum of 3 quarters · filed 2025-03-17
$43.86M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31$12.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$23.35M
derived: sum of 2 quarters · filed 2025-03-17
$34.85M
derived: sum of 3 quarters · filed 2025-03-17
$46.54M
10-K · filed 2025-03-17
2022-09-30$11.11M
10-Q · filed 2023-11-09
$22.61M
derived: sum of 2 quarters · filed 2023-11-09
$34.30M
10-Q · filed 2023-11-09
$47.18M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$11.50M
10-Q · filed 2023-08-04
$23.19M
10-Q · filed 2023-08-04
$36.07M
derived: sum of 3 quarters · filed 2024-02-27
$49.20M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$11.70M
10-Q · filed 2023-05-05
$24.57M
derived: sum of 2 quarters · filed 2024-02-27
$37.71M
derived: sum of 3 quarters · filed 2024-02-27
$49.95M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$12.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$26.01M
derived: sum of 2 quarters · filed 2024-02-27
$38.25M
derived: sum of 3 quarters · filed 2024-02-27
$50.27M
10-K · filed 2024-02-27
2021-09-30$13.14M
10-Q · filed 2022-11-04
$25.38M
derived: sum of 2 quarters · filed 2022-11-04
$37.40M
10-Q · filed 2022-11-04
$47.58M
derived: sum of 4 quarters · filed 2023-03-03
2021-06-30$12.24M
10-Q · filed 2022-08-05
$24.26M
10-Q · filed 2022-08-05
$34.45M
derived: sum of 3 quarters · filed 2023-03-03
$46.47M
derived: sum of 4 quarters · filed 2023-03-03
2021-03-31$12.02M
10-Q · filed 2022-05-06
$22.21M
derived: sum of 2 quarters · filed 2023-03-03
$34.23M
derived: sum of 3 quarters · filed 2023-03-03
$43.50M
derived: sum of 4 quarters · filed 2023-03-03
2020-12-31$10.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03
$22.21M
derived: sum of 2 quarters · filed 2023-03-03
$31.48M
derived: sum of 3 quarters · filed 2023-03-03
$42.68M
10-K · filed 2023-03-03
2020-09-30$12.02M
10-Q · filed 2021-11-05
$21.30M
derived: sum of 2 quarters · filed 2021-11-05
$32.49M
10-Q · filed 2021-11-05
$44.45M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30$9.28M
10-Q · filed 2021-08-06
$20.47M
10-Q · filed 2021-08-06
$32.43M
derived: sum of 3 quarters · filed 2022-03-04
$42.65M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$11.19M
10-Q · filed 2021-05-07
$23.16M
derived: sum of 2 quarters · filed 2022-03-04
$33.38M
derived: sum of 3 quarters · filed 2022-03-04
$43.52M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$11.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$22.18M
derived: sum of 2 quarters · filed 2022-03-04
$32.33M
derived: sum of 3 quarters · filed 2022-03-04
$43.03M
10-K · filed 2022-03-04
2019-09-30$10.22M
10-Q · filed 2020-11-06
$20.37M
derived: sum of 2 quarters · filed 2020-11-06
$31.07M
10-Q · filed 2020-11-06
$40.47M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$10.15M
10-Q · filed 2020-08-07
$20.85M
10-Q · filed 2020-08-07
$30.25M
derived: sum of 3 quarters · filed 2021-03-05
$39.41M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$10.70M
10-Q · filed 2020-05-08
$20.10M
derived: sum of 2 quarters · filed 2021-03-05
$29.27M
derived: sum of 3 quarters · filed 2021-03-05
$37.02M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$9.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$18.56M
derived: sum of 2 quarters · filed 2021-03-05
$26.32M
derived: sum of 3 quarters · filed 2021-03-05
$35.27M
10-K · filed 2021-03-05
2018-09-30$9.17M
10-Q · filed 2019-11-08
$16.92M
derived: sum of 2 quarters · filed 2019-11-08
$25.88M
10-Q · filed 2019-11-08
$34.54M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$7.76M
10-Q · filed 2019-08-08
$16.71M
10-Q · filed 2019-08-08
$25.38M
derived: sum of 3 quarters · filed 2020-03-06
$32.50M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$8.96M
10-Q · filed 2019-05-08
$17.62M
derived: sum of 2 quarters · filed 2020-03-06
$24.74M
derived: sum of 3 quarters · filed 2020-03-06
$33.19M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$8.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$15.78M
derived: sum of 2 quarters · filed 2020-03-06
$24.23M
derived: sum of 3 quarters · filed 2020-03-06
$34.22M
10-K · filed 2020-03-06
2017-09-30$7.12M
10-Q · filed 2018-11-08
$15.57M
derived: sum of 2 quarters · filed 2018-11-08
$25.56M
10-Q · filed 2018-11-08
$34.39M
derived: sum of 4 quarters · filed 2019-03-08
2017-06-30$8.45M
10-Q · filed 2018-08-09
$18.44M
10-Q · filed 2018-08-09
$27.27M
derived: sum of 3 quarters · filed 2019-03-08
$34.61M
derived: sum of 4 quarters · filed 2019-03-08
2017-03-31$9.98M
10-Q · filed 2018-05-04
$18.82M
derived: sum of 2 quarters · filed 2019-03-08
$26.16M
derived: sum of 3 quarters · filed 2019-03-08
$33.17M
derived: sum of 4 quarters · filed 2019-03-08
2016-12-31$8.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08
$16.17M
derived: sum of 2 quarters · filed 2019-03-08
$23.19M
derived: sum of 3 quarters · filed 2019-03-08
$31.20M
10-K · filed 2019-03-08
2016-09-30$7.34M
10-Q · filed 2017-11-09
$14.36M
derived: sum of 2 quarters · filed 2017-11-09
$22.36M
10-Q · filed 2017-11-09
$30.07M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$7.02M
10-Q · filed 2017-08-04
$15.02M
10-Q · filed 2017-08-04
$22.73M
derived: sum of 3 quarters · filed 2018-03-14
$29.28M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$8.01M
10-Q · filed 2017-05-05
$15.71M
derived: sum of 2 quarters · filed 2018-03-14
$22.26M
derived: sum of 3 quarters · filed 2018-03-14
$28.62M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$7.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$14.25M
derived: sum of 2 quarters · filed 2018-03-14
$20.62M
derived: sum of 3 quarters · filed 2018-03-14
$26.45M
10-K · filed 2018-03-14
2015-09-30$6.55M
10-Q · filed 2016-11-04
$12.91M
derived: sum of 2 quarters · filed 2016-11-04
$18.74M
10-Q · filed 2016-11-04
$25.16M
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30$6.36M
10-Q · filed 2016-08-05
$12.19M
10-Q · filed 2016-08-05
$18.61M
derived: sum of 3 quarters · filed 2017-03-03
$25.77M
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31$5.83M
10-Q · filed 2016-05-06
$12.25M
derived: sum of 2 quarters · filed 2017-03-03
$19.41M
derived: sum of 3 quarters · filed 2017-03-03
$25.72M
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31$6.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
$13.58M
derived: sum of 2 quarters · filed 2017-03-03
$19.89M
derived: sum of 3 quarters · filed 2017-03-03
$28.30M
10-K · filed 2017-03-03
2014-09-30$7.16M
10-Q · filed 2015-11-05
$13.48M
derived: sum of 2 quarters · filed 2015-11-05
$21.88M
10-Q · filed 2015-11-05
$27.90M
derived: sum of 4 quarters · filed 2016-03-04
2014-06-30$6.32M
10-Q · filed 2015-08-06
$14.72M
10-Q · filed 2015-08-06
$20.74M
derived: sum of 3 quarters · filed 2016-03-04
$26.77M
derived: sum of 4 quarters · filed 2016-03-04
2014-03-31$8.40M
10-Q · filed 2015-05-08
$14.43M
derived: sum of 2 quarters · filed 2016-03-04
$20.45M
derived: sum of 3 quarters · filed 2016-03-04
$25.99M
derived: sum of 4 quarters · filed 2016-03-04
2013-12-31$6.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04
$12.05M
derived: sum of 2 quarters · filed 2016-03-04
$17.59M
derived: sum of 3 quarters · filed 2016-03-04
$24.81M
10-K · filed 2016-03-04
2013-09-30$6.03M
10-Q · filed 2014-11-07
$11.56M
derived: sum of 2 quarters · filed 2014-11-07
$18.78M
10-Q · filed 2014-11-07
$24.55M
derived: sum of 4 quarters · filed 2015-03-04
2013-06-30$5.53M
10-Q · filed 2014-08-06
$12.75M
10-Q · filed 2014-08-06
$18.52M
derived: sum of 3 quarters · filed 2015-03-04
$24.17M
derived: sum of 4 quarters · filed 2015-03-04
2013-03-31$7.22M
10-Q · filed 2014-05-08
$12.99M
derived: sum of 2 quarters · filed 2015-03-04
$18.64M
derived: sum of 3 quarters · filed 2015-03-04
$23.85M
derived: sum of 4 quarters · filed 2015-03-04
2012-12-31$5.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04
$11.42M
derived: sum of 2 quarters · filed 2015-03-04
$16.64M
derived: sum of 3 quarters · filed 2015-03-04
$22.72M
10-K · filed 2015-03-04
2012-09-30$5.65M
10-Q · filed 2013-11-07
$10.86M
derived: sum of 2 quarters · filed 2013-11-07
$16.95M
10-Q · filed 2013-11-07
$21.95M
derived: sum of 4 quarters · filed 2014-03-04
2012-06-30$5.22M
10-Q · filed 2013-08-08
$11.30M
10-Q · filed 2013-08-08
$16.31M
derived: sum of 3 quarters · filed 2014-03-04
$20.50M
derived: sum of 4 quarters · filed 2014-03-04
2012-03-31$6.08M
10-Q · filed 2013-05-08
$11.09M
derived: sum of 2 quarters · filed 2014-03-04
$15.29M
derived: sum of 3 quarters · filed 2014-03-04
$19.12M
derived: sum of 4 quarters · filed 2014-03-04
2011-12-31$5.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04
$9.20M
derived: sum of 2 quarters · filed 2014-03-04
$13.04M
derived: sum of 3 quarters · filed 2014-03-04
$18.73M
10-K · filed 2014-03-04
2011-09-30$4.19M
10-Q · filed 2012-11-07
$8.03M
derived: sum of 2 quarters · filed 2012-11-07
$13.72M
10-Q · filed 2012-11-07
$16.08M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$3.83M
10-Q · filed 2012-08-10
$9.53M
10-Q · filed 2012-08-10
$11.89M
derived: sum of 3 quarters · filed 2013-03-01
$15.38M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$5.70M
10-Q · filed 2012-05-11
$8.06M
derived: sum of 2 quarters · filed 2013-03-01
$11.55M
derived: sum of 3 quarters · filed 2013-03-01
$14.21M
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31$2.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$5.85M
derived: sum of 2 quarters · filed 2013-03-01
$8.51M
derived: sum of 3 quarters · filed 2013-03-01
$13.86M
10-K · filed 2013-03-01
2010-09-30$3.49M
10-Q · filed 2011-11-08
$6.15M
derived: sum of 2 quarters · filed 2011-11-08
$11.50M
10-Q · filed 2011-11-08
2010-06-30$2.66M
10-Q · filed 2011-08-12
$8.01M
10-Q · filed 2011-08-12
2009-12-31$13.70M
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14